Clinical trial
Observation on Efficacy and Safety of Atorvastatin Combined With Escitalopram in Patients With Depressive Episode Complicated by Dyslipidemia
NCT07712367 is registered in ClinicalTrials.gov with Hengshui City Seventh People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observation on Efficacy and Safety of Atorvastatin Combined With Escitalopram in Patients With Depressive Episode Complicated by Dyslipidemia
- Lead sponsor
- Hengshui City Seventh People's Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2025
- Completion date
- May 27, 2026
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depressive episode, dyslipidemia